BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24579933)

  • 1. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.
    Hanas JS; Peyton MD; Lerner MR; Lightfoot SA; Deb SJ; Hanas RJ; Vu NT; Kupiec TC; Stowell DE; Brackett DJ; Dubinett SM; Hocker JR
    Cancer Invest; 2014 May; 32(4):136-43. PubMed ID: 24579933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry.
    Hocker JR; Peyton MD; Lerner MR; Mitchell SL; Lightfoot SA; Lander TJ; Bates-Albers LM; Vu NT; Hanas RJ; Kupiec TC; Brackett DJ; Hanas JS
    Lung Cancer; 2011 Nov; 74(2):206-11. PubMed ID: 21529985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexisting pulmonary nodules in operable lung cancer: prevalence and probability of malignancy.
    Ruppert AM; Lerolle U; Carette MF; Lavole A; Khalil A; Bazelly B; Antoine M; Cadranel J; Milleron B
    Lung Cancer; 2011 Nov; 74(2):233-8. PubMed ID: 21511355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules.
    Vachani A; Hammoud Z; Springmeyer S; Cohen N; Nguyen D; Williamson C; Starnes S; Hunsucker S; Law S; Li XJ; Porter A; Kearney P
    Lung; 2015 Dec; 193(6):1023-7. PubMed ID: 26376647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
    Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frozen section diagnoses of small pulmonary nodules: accuracy and clinical implications.
    Marchevsky AM; Changsri C; Gupta I; Fuller C; Houck W; McKenna RJ
    Ann Thorac Surg; 2004 Nov; 78(5):1755-9. PubMed ID: 15511468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions.
    Schaefer JF; Vollmar J; Schick F; Vonthein R; Seemann MD; Aebert H; Dierkesmann R; Friedel G; Claussen CD
    Radiology; 2004 Aug; 232(2):544-53. PubMed ID: 15215548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification for lung nodules: Size isn't everything.
    Eguchi T; Adusumilli PS
    J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1557-1562. PubMed ID: 28314535
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.
    Szpechcinski A; Rudzinski P; Kupis W; Langfort R; Orlowski T; Chorostowska-Wynimko J
    Cancer Lett; 2016 May; 374(2):202-7. PubMed ID: 26854716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and diagnostic value of serum carcinoembryonic antigen and cytokeratin 19 fragment in lung cancer patients].
    Hang ZQ; Zheng MF; Huang JH
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):847-9. PubMed ID: 22335951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
    Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy.
    Okasaka T; Usami N; Mitsudomi T; Yatabe Y; Matsuo K; Yokoi K
    J Surg Oncol; 2008 Dec; 98(7):510-4. PubMed ID: 18802955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography-guided percutaneous needle biopsy of pulmonary nodules: impact of nodule size on diagnostic accuracy.
    Kothary N; Lock L; Sze DY; Hofmann LV
    Clin Lung Cancer; 2009 Sep; 10(5):360-3. PubMed ID: 19808195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis.
    Liu W; Yang J; Chi PD; Zheng X; Dai SQ; Chen H; Xu BL; Liu WL
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1346-53. PubMed ID: 24025389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.
    Kossenkov AV; Qureshi R; Dawany NB; Wickramasinghe J; Liu Q; Majumdar RS; Chang C; Widura S; Kumar T; Horng WH; Konnisto E; Criner G; Tsay JJ; Pass H; Yendamuri S; Vachani A; Bauer T; Nam B; Rom WN; Showe MK; Showe LC
    Cancer Res; 2019 Jan; 79(1):263-273. PubMed ID: 30487137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules.
    Seder CW; Kubasiak JC; Pithadia R; Basu S; Fhied C; Tarhoni I; Davila E; Alnajjar H; Chmielewski GW; Warren WH; Liptay MJ; Borgia JA
    Ann Thorac Surg; 2015 Aug; 100(2):429-36. PubMed ID: 26138771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.